Dr. Baltz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 Centerview Dr
Little Rock, AR 72211Phone+1 501-508-7163Fax+1 501-203-9850
Education & Training
University of Arkansas for Medical SciencesFellowship, Hematology and Medical Oncology, 1991 - 1994- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1988 - 1991
- University of Arkansas For Medical Sciences College of MedicineClass of 1988
Certifications & Licensure
AR State Medical License 1988 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients Start of enrollment: 2010 Jan 01
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib Start of enrollment: 2010 Nov 01
- Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. Start of enrollment: 2013 May 14
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsPrimary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosisJoseph A Chacko, Paolo Strati, Paul W Stout, Robert L. Archer, Brad P Baltz
Multiple Sclerosis and Related Disorders. 2021-01-19 - 2 citationsPembrolizumab-Induced Myocarditis and Delayed Acute Inflammatory Demyelinating Polyradiculoneuropathy.Fazal Dalal, Hussain Dalal, Brad Baltz
Cureus. 2022-07-01
Press Mentions
After Baltz Firing, CARTI Issues StatementMarch 19th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
